课题基金 / 基金详情

THE TRIALNET NATURAL HISTORY STUDY OF THE DEVELOPMENT OF TYPE 1 DIABETES

THE TRIALNET NATURAL HISTORY STUDY OF THE DEVELOPMENT OF TYPE 1 DIABETES
1 型糖尿病发展的 TrialNET 自然史研究
批准号:
7951658
负责人:
Antoinette M. Moran
金额:
$4.13万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-12-01 至 2009-11-30

项目摘要

项目成果

Antoinette M. Moran的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The goals of the TrialNet Natural History Study of the Development of T1D are to both gain information about the pathogenesis and natural history of T1D and to facilitate the recruitment and assessment of individuals who might qualify for T1D prevention trials. Importantly, the information obtained from this study will serve to enable the development and implementation of prevention trials. The design of the TrialNet Natural History Study of the Development of T1D as described below is intended to achieve these goals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Diabetes in African Youth: Improving Glucose Time-In-Range
  • 批准号:
    10565952
  • 项目类别:
  • 资助金额:
    $56.91万
  • 财政年份:
    2022
  • 负责人:
    Antoinette M. Moran
  • 依托单位:
Diabetes in African Youth: Improving Glucose Time-In-Range
  • 批准号:
    10362765
  • 项目类别:
  • 资助金额:
    $59.67万
  • 财政年份:
    2022
  • 负责人:
    Antoinette M. Moran
  • 依托单位:
The Impact of Insulin Therapy on Protein Turnover in Pre-Diabetic CF Patients
  • 批准号:
    9294124
  • 项目类别:
  • 资助金额:
    $69.2万
  • 财政年份:
    2015
  • 负责人:
    Antoinette M. Moran
  • 依托单位:
The Impact of Insulin Therapy on Protein Turnover in Pre-Diabetic CF Patients
  • 批准号:
    9115576
  • 项目类别:
  • 资助金额:
    $69.2万
  • 财政年份:
    2015
  • 负责人:
    Antoinette M. Moran
  • 依托单位: